China secures rank 1 in terms of total company revenues
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in...Read more
China, Australia dominate APAC pharma market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...Read more
China National Accord's R&D strategy begins to pay-off
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...Read more
India's 127-year-old ayurvedic leader clocks $847 mn
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...Read more
What were Asia's Top 20 bio companies in 2012?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...Read more
What were the top 20 global M&A transactions of 2012?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...Read more
Why did mergers & acquisitions plunge in APAC?
Industry Insights | Analysis | By BioSpectrum Bureau | 1 Comment | 12 Jun, 2013
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...Read more
Sanjiu Medical keeps focus on R&D
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2012
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...Read more
TCM leader Yunnan Baiyao rides on R&D strength
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...Read more
Baraclude tops Korea pharma products list
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top thr...Read more
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...Read more
Guangzhou records a whopping growth of over 50%
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...Read more
What are the key mergers & acquisitions of Q1 2013?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...Read more
Australia is 3rd largest in terms of total company revenues
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar ...Read more
What were the top 20 M&A deals in pharma and biotech sector in 2012?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...Read more
India ranks 2nd in terms of total company revenues
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...Read more